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Background: Computer assisted propofol sedation (CAPS) has been recently
approved by the FDA for moderate sedation of ASA class I and II patients under-
going routine upper endoscopy and colonoscopy. CAPS uses a continuous propofol
infusion after a single premedication dose of fentanyl. As the first U.S. medical center
to adopt CAPS technology for routine clinical use, we compared CAPS patients
against a concurrent group sedated with midazolam and fentanyl (MF). Methods:
Patients who underwent elective outpatient upper endoscopy and colonoscopy with
CAPS over a 2 month period were compared against concurrent patients sedated
with MF. All procedures were performed by 1 of 9 gastroenterologists certified in the
use of the CAPS system, with the assistance of an identically trained nurse. Proce-
dural success rates, polyp detection rates, adverse events, procedure times and re-
covery times were recorded. Patient satisfaction scores are reported in a separate
abstract. Results: CAPS was utilized to sedate 244 patients (mean age 60.4 years; 52.5%
male), of whom 55 underwent upper endoscopy, 173 colonoscopy and 16 double
procedures. The mean propofol dose was 140.1 mg for upper endoscopies, 185.7 mg
for colonoscopies and 265.3 mg for double procedures. During the same period, 75
upper endoscopies, 223 colonoscopies and 30 double procedures were performed
with MF on similar patients. For upper endoscopy, the procedural success rate was
98.2% for CAPS vs. 98.7% forMF (pZ0.82), while for colonoscopy, the success ratewas
98.9% for CAPS vs. 98.8% for MF (pZ0.90). Colonoscopic polyp detection rate was
54.5% for CAPS and 59.3% for MF (pZ0.31). For CAPS, the mean procedure time was
12.5 minutes for upper endoscopies, 25 for colonoscopies and 39.4 for double pro-
cedures; the corresponding times forMFwere 11.3, 24.8 and 40.7minutes respectively
(p>0.05 for all). For CAPS, the mean recovery time was 26.4 vs. 39.1 minutes for MF
(p<.001). For CAPS, 1 patient (0.01%) required mask ventilation for desaturation, 4
(0.02%) experienced asymptomatic hypotension or desaturation that did not require
any intervention other than reduction in the propofol rate, and 5 (0.02%) suffered
marked agitation due to undersedation. For MF, 5 patients (0.02%) had asymptomatic
hypotension or desaturation, and 8 (0.03%) suffered marked agitation from underse-
dation. No subject suffered any severe adverse event such as intubation, unanticipated
hospitalization, permanent injury or death. Conclusions: Compared to MF, CAPS re-
sulted in significantly shorter recovery times, although procedure times were similar.
Procedural success rates and polyp detection rates were high and comparable. Both
groups had few adverse events and no serious adverse events. In low-risk patients,
CAPS appears to be a safe, effective and efficient means of providing moderate
sedation for upper endoscopy and colonoscopy.
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Background: The adenoma detection rate (ADR) is the primary quality indicator for
colonoscopy. The risk of interval colorectal cancer is inversely related to the endo-
scopist’s ADR. However, ADR calculation is a time-consuming process that requires a
AbstractsAB532 GASTROINTESTINAL ENDOSCOPY Volume 83, No. 5S : 2016combination of endoscopic and histopathologic data collection. The adenoma to
polyp detection rate quotient (APDRQ) has been used as a conversion factor to
estimate ADR from polyp detection rate (PDR). However, it is unclear whether this
conversion factor could be precisely calculated from a case-mix or may vary in co-
lonoscopies with different indications. Aims: To create and compare conversion
factors that accurately estimate the ADR from the PDR in 2 different screening
populations, average risk patients (AVR) and patients with a positive fecal immune
test (FIT-positive). Methods: This was a retrospective analysis of colonoscopies
performed by 6 gastroenterologists in a single center from January 2004 to July 2015.
First time colonoscopies on AVR and FIT-positive patients were included. ADR, PDR
and APDRQ was calculated for each endoscopist. Average APDRQs for average risk
patient population (AVR-APDRQ) and FIT-positive population (FIT-APDRQ) were
used as conversion factors to estimate ADRs and FIT-ADRs of each endoscopist from
the corresponding AVR-PDRs and FIT-PDRs. The main outcome measures were the
strength of the relationship between the estimated ADRs and the actual ADRs
determined by Pearson’s correlation coefficient (r), and the average estimated-actual
differences. Results: We included 3686 colonoscopies performed on AVR and 3962
colonoscopies performed on FIT-positive patients. The average AVR-APDRQ and
FIT-APDRQ were 0.72 and 0.87, respectively. The correlation between the estimated
AVR-ADRs and the actual AVR-ADRs was 0.93 (95% CI, 0.70-1.00; pZ 0.007) whereas
the correlation between the estimated FIT-ADRs and the actual FIT-ADRs was 0.97
(95% CI, 0.83-1.00; pZ 0.002). Conclusions: The application of a conversion factor
to the PDR can accurately estimate the ADR. The accuracy is higher if the conversion
factor is targeted on specific subgroups of patients and applied to expert endo-
scopists ( 5 years of experience, > 500 colonoscopies/year).
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Background: First-case start time (FIRST) has been traditionally emphasized as an
important process measure when evaluating efficiency in the operating room
setting. However, the impact of (FIRST) on efficiency in an interventional endoscopy
unit (IEU) has not been clearly defined. Aim: Evaluate the effect of delays in FIRST
on IEU efficiency metrics. Methods: The prospectively collected endoscopy unit
metrics database at our tertiary care academic medical center was reviewed for
procedures performed in the IEU for 6 months. Parameters included hospital-
mandated metrics available from the database. First-case start time delay was defined
as any time the first patient of the day entered the endoscopy room after the
scheduled time. The FIRST on-schedule group (FIRST-OS) included all patients who
underwent procedures on days in which FIRST was not delayed whereas FIRST
delayed (FIRST-D) was defined as those days in which FIRST occurred after the
scheduled time. Impact of FIRST delay (FIRST-D) was assessed on the following
efficiency metrics: (1) Room throughput, defined as the total number of patients
who underwent endoscopic procedures per room/day; (2) Room total time (TT),
which was defined as the total time (min) elapsed in the IEU that day. Regression
analyses were performed to evaluate the effect of FIRST on throughput and TT per
day. In a subgroup analysis, effect of increasing lengths of delay in FIRST (1-5, 6-10,
11-15, 16-20 and >20 minutes) was also evaluated. Results: 1421 patients (52.5%
male;median age 63 years [range 14 – 91 years]) underwent a total of 1635 endoscopic
procedures in two interventional endoscopy roomswith a total of 247 first cases. FIRST
was delayed 60% (148/247). There were no statistically significant differences in
baseline characteristics (age, sex, BMI, Charlson comorbidity index score, inpatient vs.
outpatient and endotracheal intubation status) between FIRST-OS and FIRST-D
groups. There was no significant difference in room throughput (FIRST-OS 5.7 cases/
day vs. FIRST-D 5.6 cases/day; pZ 0.82) or TT (FIRSTOS 466.8minutes/day vs FIRST-D
467.2 minutes/day, pZ0.93). Linear regression analysis showed that FIRST-D did not
affect the number of cases per day (p-valueZ 0.325) or TT per day (p-valueZ 0.468)
(Figure 1). There was no significant difference in room throughput or TT between
FIRST-OS and FIRST-D; irrespective of the amount of time FIRST was delayed.
Conclusion: First-case start time did not affect room throughput or total time in our
interventional endoscopy unit. Though first-case start time has been conventionally
emphasized as a quality measure, attention should be directed towards identifying
and evaluating other operational metrics in the endoscopy unit.
Table 1Patient CharacteristicsFirst Casewww.giejoup valueFIRST-OS FIRST-DN 99 148
Age, mean  SD, year 61.9  14.1 61.6  14.3 0.82
BMI, mean  SD, kg/m2 27.8  5.4 27.5  7 0.24rnal.org
